ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $36,467,000 | +119.0% | 1,746,500 | +2.5% | 10.54% | +30.5% |
| Q1 2020 | $16,653,000 | +1.6% | 1,704,500 | +19.8% | 8.07% | +98.9% |
| Q4 2019 | $16,387,000 | +15.8% | 1,422,500 | +19.5% | 4.06% | -19.3% |
| Q2 2019 | $14,149,000 | +193.8% | 1,190,000 | +29.5% | 5.03% | +119.7% |
| Q1 2019 | $4,816,000 | – | 919,000 | – | 2.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |